AHI Stock Overview Operates as a mobile application and technology development company in Australia and internationally. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Add noteAdvanced Health Intelligence Ltd Competitors Price History & Performance
Summary of share price highs, lows and changes for Advanced Health Intelligence Historical stock prices Current Share Price AU$0.092 52 Week High AU$0.28 52 Week Low AU$0.073 Beta 1.46 1 Month Change 0% 3 Month Change 6.98% 1 Year Change 15.00% 3 Year Change -94.74% 5 Year Change -63.92% Change since IPO 104.44%
Recent News & Updates Advanced Health Intelligence Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.272075 million. Dec 02
Advanced Health Intelligence Ltd, Annual General Meeting, Nov 29, 2024 Oct 30
Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index Jul 30 Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million. Apr 16
Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million. Feb 27
Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Dec 02 See more updates Advanced Health Intelligence Ltd has completed a Follow-on Equity Offering in the amount of AUD 2.272075 million. Dec 02
Advanced Health Intelligence Ltd, Annual General Meeting, Nov 29, 2024 Oct 30
Advanced Health Intelligence Ltd(NasdaqCM:AHI) dropped from NASDAQ Composite Index Jul 30 Advanced Health Intelligence Ltd has filed a Follow-on Equity Offering in the amount of AUD 1.9575 million. Apr 16
Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 0.2 million. Feb 27
Advanced Health Intelligence Ltd to Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Dec 02
Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million. Nov 07 Advanced Health Intelligence Ltd. has filed a Follow-on Equity Offering in the amount of AUD 2.1995 million. Nov 06
Advanced Health Intelligence Ltd. announced delayed 20-F filing Nov 01
Advanced Health Intelligence Ltd., Annual General Meeting, Nov 17, 2023 Oct 19 Advanced Health Intelligence Ltd. announced that it has received AUD 1.5 million in funding Sep 13
Full year 2023 earnings released: AU$0.072 loss per share (vs AU$0.13 loss in FY 2022) Sep 01
New minor risk - Financial data availability Aug 31 Advanced Health Intelligence Ltd. has completed a Follow-on Equity Offering in the amount of AUD 5 million. Jun 15
First half 2023 earnings released: AU$0.024 loss per share (vs AU$0.10 loss in 1H 2022) Mar 03
High number of new directors Jan 31
Advanced Health Intelligence Ltd. Announces Board Changes Dec 20
Advanced Human Imaging Limited (ASX:AHI) completed the acquisition of WellteQ Digital Health Inc. (CNSX:WTEQ). Dec 08 Advanced Human Imaging Appoints Dr. Peter Vaughan as Non-Executive Director
Advanced Human Imaging Limited announced delayed 20-F filing Nov 01
Advanced Human Imaging Limited, Annual General Meeting, Nov 29, 2022 Oct 31
Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.11 loss in FY 2021) Oct 17
Forecast breakeven date pushed back to 2025 Oct 15
Forecast breakeven date pushed back to 2025 Sep 13
Full year 2022 earnings released: AU$0.13 loss per share (vs AU$0.11 loss in FY 2021) Sep 05
Advanced Human Imaging Limited (ASX:AHI) executed a non-binding letter of intent to acquire WellteQ Digital Health Inc. (CNSX:WTEQ) for AUD 4.3 million. Sep 03
Advanced Human Imaging Ltd Appoints Peter Goldstein as Non-Executive Director Jun 29
Advanced Human Imaging Limited to Be Deleted from Other OTC Jun 02
Advanced Human Imaging Limited Announces Resignation of Edward Greissing Jr as Director May 28
First half 2022 earnings: Revenues and EPS in line with analyst expectations Mar 03
Forecast to breakeven in 2023 Mar 02
Advanced Human Imaging Limited Appoints Dr. Katherine Iscoe as Director Feb 16 Advanced Human Imaging Limited Announces Executive Changes
Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020) Oct 04
Advanced Human Imaging Limited Announces the Submission of the Health Cube App into the Top 10 China App Stores with Tinjoy Biotech Limited Sep 15
No independent directors Sep 06
Full year 2021 earnings released: AU$0.11 loss per share (vs AU$0.052 loss in FY 2020) Sep 02
Advanced Human Imaging Limited Announces Derma AI Embedded in the AHI DermaScan Receives CE Mark Clearance in the European Union for the Dermatology AI Component in CompleteScan May 28
Advanced Human Imaging's DermaScan AI Receives Medical Device Approval 27 EU Countries (CE Mark) May 27
Advanced Human Imaging Limited to Launch BodyScan in Original Fit Factory's Fitness App Truconnect to Audience of 150+ Million May 05
New 90-day high: AU$2.17 Mar 04
First half 2021 earnings released: AU$0.046 loss per share (vs AU$0.029 loss in 1H 2020) Mar 03
MyFiziq Limited to Appoint New US Board Members in Readiness for Nasdaq Feb 26
MyFiziq Names William Bradford as New Global Chief Business Officer in USA Feb 24
New 90-day high: AU$1.35 Feb 09
MyFiziq Signs Marketing and Expansion Agreement with Bearn Jan 23
MyFiziq Limited Announces Management Changes Jan 22
Myfiziq Limited Releases Applications with Biomorphik Pty Ltd App with the Myfiziq Technology Jan 06
MyFiziq Limited Completes Definitive Agreements with MVMNT Inc Oct 20
MyFiziq Limited announced that it expects to receive AUD 5 million in funding Oct 14
MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited Oct 08
Myfiziq Limited Signs Agreement with Nexus-Vita with USD 3.5 Million Guarantee Oct 06
MyFiziq Limited Auditor Raises 'Going Concern' Doubt Oct 04
Full year earnings released - AU$0.052 loss per share Oct 03
New 90-day high: AU$1.16 Sep 29
MyFiziq Limited Signs Definitive Agreements with Biomorphik to Accelerate A November 2020 Release Sep 17
New 90-day high - AU$0.59 Sep 11
Full year earnings released - AU$0.052 loss per share Sep 02
New 90-day high - AU$0.32 Aug 21
New 90-day high - AU$0.29 Jul 21 Shareholder Returns AHI AU Healthcare Services AU Market 7D 0% -1.5% -0.06% 1Y 15.0% 142.5% 9.0%
See full shareholder returns
Return vs Market: AHI exceeded the Australian Market which returned 4.3% over the past year.
Price Volatility Is AHI's price volatile compared to industry and market? AHI volatility AHI Average Weekly Movement n/a Healthcare Services Industry Average Movement 9.4% Market Average Movement 8.0% 10% most volatile stocks in AU Market 16.6% 10% least volatile stocks in AU Market 3.0%
Stable Share Price: AHI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AHI's volatility change over the past year.
About the Company Founded Employees CEO Website 2014 n/a Scott Montgomery www.ahi.tech
Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual’s health. The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner.
Show more Advanced Health Intelligence Ltd Fundamentals Summary How do Advanced Health Intelligence's earnings and revenue compare to its market cap? AHI fundamental statistics Market cap AU$22.60m Earnings (TTM ) -AU$16.66m Revenue (TTM ) n/a
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) AHI income statement (TTM ) Revenue -AU$924.86k Cost of Revenue AU$7.14m Gross Profit -AU$8.07m Other Expenses AU$8.59m Earnings -AU$16.66m
Last Reported Earnings
Dec 31, 2023
Earnings per share (EPS) -0.068 Gross Margin 872.18% Net Profit Margin 1,800.92% Debt/Equity Ratio -105.6%
How did AHI perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/04/29 23:34 End of Day Share Price 2024/02/01 00:00 Earnings 2023/12/31 Annual Earnings 2023/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Advanced Health Intelligence Ltd is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Allen Klee Maxim Group
Show 0 more analysts